Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1975 1
1976 1
1977 1
1978 1
1979 1
1981 1
1985 2
1986 3
1987 1
1988 2
1989 4
1990 3
1991 3
1992 2
1993 2
1994 3
1996 4
1998 2
1999 4
2000 7
2001 4
2002 10
2003 12
2004 8
2005 15
2006 10
2007 13
2008 14
2009 16
2010 18
2011 13
2012 20
2013 18
2014 25
2015 16
2016 16
2017 12
2018 17
2019 19
2020 23
2021 15
2022 18
2023 24
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Advances and highlights in biomarkers of allergic diseases.
Ogulur I, Pat Y, Ardicli O, Barletta E, Cevhertas L, Fernandez-Santamaria R, Huang M, Bel Imam M, Koch J, Ma S, Maurer DJ, Mitamura Y, Peng Y, Radzikowska U, Rinaldi AO, Rodriguez-Coira J, Satitsuksanoa P, Schneider SR, Wallimann A, Zhakparov D, Ziadlou R, Brüggen MC, van de Veen W, Sokolowska M, Baerenfaller K, Zhang L, Akdis M, Akdis CA. Ogulur I, et al. Among authors: mitamura y. Allergy. 2021 Dec;76(12):3659-3686. doi: 10.1111/all.15089. Epub 2021 Sep 27. Allergy. 2021. PMID: 34519063 Free PMC article. Review.
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease.
Celebi Sozener Z, Ozdel Ozturk B, Cerci P, Turk M, Gorgulu Akin B, Akdis M, Altiner S, Ozbey U, Ogulur I, Mitamura Y, Yilmaz I, Nadeau K, Ozdemir C, Mungan D, Akdis CA. Celebi Sozener Z, et al. Among authors: mitamura y. Allergy. 2022 May;77(5):1418-1449. doi: 10.1111/all.15240. Epub 2022 Feb 16. Allergy. 2022. PMID: 35108405 Free PMC article. Review.
Type 2 immunity in the skin and lungs.
Akdis CA, Arkwright PD, Brüggen MC, Busse W, Gadina M, Guttman-Yassky E, Kabashima K, Mitamura Y, Vian L, Wu J, Palomares O. Akdis CA, et al. Among authors: mitamura y. Allergy. 2020 Jul;75(7):1582-1605. doi: 10.1111/all.14318. Epub 2020 May 10. Allergy. 2020. PMID: 32319104 Review.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Advances and recent developments in asthma in 2020.
Cevhertas L, Ogulur I, Maurer DJ, Burla D, Ding M, Jansen K, Koch J, Liu C, Ma S, Mitamura Y, Peng Y, Radzikowska U, Rinaldi AO, Satitsuksanoa P, Globinska A, van de Veen W, Sokolowska M, Baerenfaller K, Gao YD, Agache I, Akdis M, Akdis CA. Cevhertas L, et al. Among authors: mitamura y. Allergy. 2020 Dec;75(12):3124-3146. doi: 10.1111/all.14607. Epub 2020 Oct 16. Allergy. 2020. PMID: 32997808 Review.
Single-cell analysis of allergic diseases.
Mitamura Y, Akdis CA. Mitamura Y, et al. Allergy. 2023 Feb;78(2):346-348. doi: 10.1111/all.15581. Allergy. 2023. PMID: 36707981 No abstract available.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
374 results